{"id":96609,"date":"2023-10-08T13:09:00","date_gmt":"2023-10-08T06:09:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2023100813090096609"},"modified":"2023-10-08T16:42:57","modified_gmt":"2023-10-08T08:42:57","slug":"2023-ash-%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f10%e9%a1%b9%e7%a0%94%e7%a9%b6%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b8%e5%9b%bd%e9%99%85%e8%88%9e%e5%8f%b0","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2023100813090096609","title":{"rendered":"2023 ASH&#8211;\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f10\u9879\u7814\u7a76\u6210\u679c\u4eae\u76f8\u56fd\u9645\u821e\u53f0"},"content":{"rendered":"<p><p><span class=\"legendSpanClass\">\u5317\u4eac<\/span><span class=\"legendSpanClass\">2023\u5e7410\u67088\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u7b2c65\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\uff08ASH\uff09\u5e74\u4f1a\u5c06\u4e8e2023\u5e7412\u67089\u65e5~12\u65e5\u5728\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u5723\u5730\u4e9a\u54e5\u4e3e\u884c\uff0c\u4f5c\u4e3a\u5168\u7403\u8840\u6db2\u75c5\u9886\u57df\u7684\u6743\u5a01\u5b66\u672f\u76db\u4f1a\u4e4b\u4e00\uff0cASH\u5e74\u4f1a\u4e0a\u5448\u73b0\u7684\u5b66\u672f\u62a5\u544a\u4ee3\u8868\u4e86\u8840\u6db2\u75c5\u9886\u57df\u7684\u6700\u91cd\u8981\u53ca\u524d\u6cbf\u7684\u7814\u7a76\u6210\u679c\u3002\u6765\u81ea\u5168\u7403\u8fd1100\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u7684\u6570\u4e07\u540d\u8840\u6db2\u75c5\u4e13\u5bb6\u5b66\u8005\u53ca\u884c\u4e1a\u76f8\u5173\u4eba\u58eb\u53c2\u4f1a\uff0c\u5206\u4eab\u548c\u63a2\u8ba8\u5168\u7403<span id=\"spanHghlt8055\">\u524d<\/span>\u6cbf\u7684\u7814\u7a76\u8fdb\u5c55\u548c\u7a81\u7834\u6027\u4e34\u5e8a\u7814\u7a76\u6210\u679c\u53ca\u5b9d\u8d35\u7684\u4e34\u5e8a\u5b9e\u8df5\u7ecf\u9a8c\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1793\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2241432\/image_844202_19998304.html\" target=\"_blank\" rel=\"nofollow noopener\"><img decoding=\"async\" src=\"https:\/\/www.xinwengao.com\/cn\/wp-content\/uploads\/image_844202_19998304.jpg\" title=\"\" alt=\"\" \/><\/a><br \/><span><\/span><\/p>\n<\/p><\/div>\n<p>\u4e8c\u5341\u4f59\u5e74\u6765\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u89c1\u8bc1\u548c\u53c2\u4e0e\u4e86\u4e2d\u56fd\u8840\u6db2\u4e8b\u4e1a\u7684\u5feb\u901f\u53d1\u5c55\uff0c\u4e5f\u4ece\u672a\u5728\u4e16\u754c\u8840\u6db2\u75c5\u9886\u57df\u5b66\u672f\u4f1a\u8bae\u4e0a\u7f3a\u5e2d\uff0c\u672c\u5c4a\u5e74\u4f1a\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u4ee51\u9879\u53e3\u5934\u62a5\u544a\u30019\u9879\u5899\u62a5\u5c55\u793a\u7684\u4f18\u5f02\u6210\u7ee9\u518d\u6b21\u5728\u56fd\u9645\u4f1a\u8bae\u4e0a\u5c55\u793a\u4e2d\u56fd\u5b9e\u529b\u3002<\/p>\n<p><b>ORAL(\u53e3\u5934\u62a5\u544a)<br \/><\/b><\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>218&nbsp; &nbsp;\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u5f26\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/><\/b>\u9898\u76ee\uff1aNaturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory\/Relapsed Acute Myeloid Leukemia: Phase \u2160 Clinical Trial<\/p>\n<p><b>POSTER(\u5899\u62a5\u5c55\u793a)<br \/><\/b><\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>1414&nbsp; &nbsp;\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u4f73\u7426\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/><\/b>\u9898\u76ee\uff1aPartner Gene Associated Trinary Fusion and Orchestration of Multiple Molecular Events in Acute Promyelocytic Leukemia with Variant Rara Fusion Genes<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>1566&nbsp; &nbsp;\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f <br \/><\/b>\u9898\u76ee\uff1aAdvances in Acute Myeloid Leukemia Classification: A Comparative Analysis of WHO 2016, WHO 2022, and International Consensus Classification<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>1576&nbsp; \u7b2c\u4e00\u4f5c\u8005\uff1a\u5468\u6653\u82cf\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/><\/b>\u9898\u76ee\uff1aThe Ingenious Multiple Efficacies of the Integrated Gene Fragment of Torque Teno Mini Virus in Orchestrating Promyelocytic Leukemogenesis via Hijacking RARA<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>1610&nbsp; \u7b2c\u4e00\u4f5c\u8005\uff1a\u5218\u94ed\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/><\/b>\u9898\u76ee\uff1aDeciphering the Structural Variants in B Cell Acute Lymphoblastic Leukemia By Optical Genome Mapping<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>2107&nbsp; \u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u5f26\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/><\/b>\u9898\u76ee\uff1aHigh Efficacy and Safety of Nanobody Based Anti-BCMA CAR-T cell Therapy in Treating Patients with Relapsed or Refractory Multiple Myeloma&nbsp;<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>2155&nbsp; \u7b2c\u4e00\u4f5c\u8005\uff1a\u66f9\u661f\u7389\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/><\/b>\u9898\u76ee\uff1aCD7 CAR-T Therapy Followed By a Second Transplant for T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients Who Relapsed after a Prior Transplant<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>2949&nbsp; \u7b2c\u4e00\u4f5c\u8005\uff1a\u5468\u6653\u82cf\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/><\/b>\u9898\u76ee\uff1aTrinary Fusion with Ligand Binding Domain Castration is Crucial in RARG-driven APL and Render Unresponsive to ATRA via Allosteric Disability Mechanism<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>3611&nbsp; \u7b2c\u4e00\u4f5c\u8005\uff1a\u66f9\u661f\u7389\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/><\/b>\u9898\u76ee\uff1aA Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL\/LBL Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation<\/p>\n<p><b>\u6458\u8981\u53f7\uff1a<\/b><b>4348&nbsp; \u7b2c\u4e00\u4f5c\u8005\uff1a\u738b\u5f64\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/><\/b>\u9898\u76ee\uff1aJAK2 Kinase Fusion and Myeloid Involvement in Acute Lymphoblastic Leukemia<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prnpr2 prnpl2 prnsbtb0 prnrbrb0 prnsbbb0 prnsblb0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">\u6ce8\uff1a\u4e0a\u8ff0\u7814\u7a76\u6210\u679c\u6309\u6458\u8981\u53f7\u6392\u5e8f<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>\u4f5c\u4e3a\u4e2d\u56fd\u4e43\u81f3\u5168\u7403\u4eab\u8a89\u76db\u540d\u7684\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u4e2d\u5fc3\u4e4b\u4e00\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u4e34\u5e8a\u4e0e\u5b9e\u9a8c\u5ba4\u68c0\u9a8c\u901a\u529b\u534f\u4f5c\uff0c\u5728\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u548c\u514d\u75ab\u6cbb\u7597\u65b9\u9762\u6bcf\u5e74\u90fd\u6709\u6700\u65b0\u7684\u7814\u7a76\u6210\u679c\u5448\u73b0\u3002\u68c0\u9a8c\u533b\u5b66\u56e2\u961f\u7528\u7cbe\u51c6MICM\u68c0\u6d4b\u4e3a\u4e34\u5e8a\u8bca\u7597\u63d0\u4f9b\u652f\u6301\uff0c\u540c\u65f6\u4e0d\u65ad\u5206\u6790\u548c\u603b\u7ed3\uff0c\u5728\u8840\u6db2\u75c5\u75c5\u7406\u548c\u533b\u5b66\u68c0\u6d4b\u65b9\u9762\u7814\u7a76\u6210\u679c\u9887\u4e30\u3002<\/p>\n<p>\u6211\u4eec\u4f1a\u9646\u7eed\u63a8\u51fa\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u4e0a\u8ff0\u7814\u7a76\u6210\u679c\u7684\u8be6\u7ec6\u62a5\u9053\uff0c\u8bf7\u6301\u7eed\u5173\u6ce8\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\">  <\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u5317\u4eac2023\u5e7410\u67088\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u7b2c65\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\uff08ASH\uff09\u5e74\u4f1a\u5c06\u4e8e2023\u5e7412\u67089\u65e5~12\u65e5\u5728\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u5723\u5730\u4e9a\u54e5\u4e3e\u884c\uff0c\u4f5c\u4e3a\u5168\u7403\u8840\u6db2\u75c5\u9886\u57df\u7684\u6743\u5a01\u5b66\u672f\u76db\u4f1a\u4e4b\u4e00\uff0cASH\u5e74\u4f1a\u4e0a\u5448\u73b0\u7684\u5b66\u672f\u62a5\u544a\u4ee3\u8868\u4e86\u8840\u6db2\u75c5\u9886\u57df\u7684\u6700\u91cd\u8981\u53ca\u524d\u6cbf\u7684\u7814\u7a76\u6210\u679c\u3002\u6765\u81ea\u5168\u7403\u8fd1100\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u7684\u6570\u4e07\u540d\u8840\u6db2\u75c5\u4e13\u5bb6\u5b66\u8005\u53ca\u884c\u4e1a\u76f8\u5173\u4eba\u58eb\u53c2\u4f1a\uff0c\u5206\u4eab\u548c\u63a2\u8ba8\u5168\u7403\u524d\u6cbf\u7684\u7814\u7a76\u8fdb\u5c55\u548c\u7a81\u7834\u6027\u4e34\u5e8a\u7814\u7a76\u6210\u679c\u53ca\u5b9d\u8d35\u7684\u4e34\u5e8a\u5b9e\u8df5\u7ecf\u9a8c\u3002 \u4e8c\u5341\u4f59\u5e74\u6765\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u89c1\u8bc1\u548c\u53c2\u4e0e\u4e86\u4e2d\u56fd\u8840\u6db2\u4e8b\u4e1a\u7684\u5feb\u901f\u53d1\u5c55\uff0c\u4e5f\u4ece\u672a\u5728\u4e16\u754c\u8840\u6db2\u75c5\u9886\u57df\u5b66\u672f\u4f1a\u8bae\u4e0a\u7f3a\u5e2d\uff0c\u672c\u5c4a\u5e74\u4f1a\uff0c\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u4ee51\u9879\u53e3\u5934\u62a5\u544a\u30019\u9879\u5899\u62a5\u5c55\u793a\u7684\u4f18\u5f02\u6210\u7ee9\u518d\u6b21\u5728\u56fd\u9645\u4f1a\u8bae\u4e0a\u5c55\u793a\u4e2d\u56fd\u5b9e\u529b\u3002 ORAL(\u53e3\u5934\u62a5\u544a) \u6458\u8981\u53f7\uff1a218&nbsp; &nbsp;\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u5f26\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e\u9898\u76ee\uff1aNaturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory\/Relapsed Acute Myeloid Leukemia: Phase \u2160 Clinical Trial POSTER(\u5899\u62a5\u5c55\u793a) \u6458\u8981\u53f7\uff1a1414&nbsp; &nbsp;\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u4f73\u7426\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f\u9898\u76ee\uff1aPartner Gene Associated Trinary Fusion and Orchestration of Multiple Molecular Events in Acute Promyelocytic Leukemia with Variant Rara Fusion Genes \u6458\u8981\u53f7\uff1a1566&nbsp; &nbsp;\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f \u9898\u76ee\uff1aAdvances in Acute Myeloid Leukemia Classification:&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2023100813090096609\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":96612,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-96609","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/96609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=96609"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/96609\/revisions"}],"predecessor-version":[{"id":96611,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/96609\/revisions\/96611"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/96612"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=96609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=96609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=96609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}